Document is current

Any future updates will be listed below

Long-term oral administration of an HNF4α agonist prevents weight gain and hepatic steatosis by promoting increased mitochondrial mass and function

Crossref DOI link: https://doi.org/10.1038/s41419-022-04521-5

Published Online: 2022-01-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark